Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

36.85p
   
  • Change Today:
      0.100p
  • 52 Week High: 71.80
  • 52 Week Low: 34.50
  • Currency: UK Pounds
  • Shares Issued: 540.40m
  • Volume: 334,743
  • Market Cap: £199.14m
  • RiskGrade: 119

Latest Deals

Traded Action Notifier PriceAmountValue
13-Oct-23 Sell Andrew Franklin 39.02p 42,053 £16,407.40
13-Oct-23 Exercise of option Andrew Franklin 1.00p 55,592 £555.92
13-Oct-23 Sell Peter Butterfield 39.02p 74,343 £29,005.66
13-Oct-23 Exercise of option Peter Butterfield 1.00p 98,342 £983.42
20-Jul-23 Buy Jo Le Couilliard 48.80p 40,957 £19,987.02
18-Jul-23 Buy Richard Jones 47.10p 53,000 £24,963.00
18-Jul-23 Buy Andrew Franklin 49.01p 50,988 £24,986.67

Latest Notification of Holdings

No notifications of holding were found in the last 365 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 36.85p
Change Today 0.100p
% Change 0.27 %
52 Week High 71.80
52 Week Low 34.50
Volume 334,743
Shares Issued 540.40m
Market Cap £199.14m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
82.05% above the market average82.05% above the market average82.05% above the market average82.05% above the market average82.05% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
65.04% below the market average65.04% below the market average65.04% below the market average65.04% below the market average65.04% below the market average
15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average
Income
4.26% above the market average4.26% above the market average4.26% above the market average4.26% above the market average4.26% above the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Growth
88.65% below the market average88.65% below the market average88.65% below the market average88.65% below the market average88.65% below the market average
83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 19-Apr-2024

Time Volume / Share Price
16:35 12,204 @ 36.85p
16:35 231 @ 36.85p
16:35 490 @ 36.85p
16:35 1,043 @ 36.85p
16:35 116 @ 36.85p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Camillo Pane

Top of Page